DIVISLAB vs RELIANCE
Head-to-head DCF comparison · Divi's Laboratories Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 2 of 4model metrics · not investment advice
DIVISLAB
Divi's Laboratories Limited
Pharma
₹6,268
OvervaluedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Fairly Valued| Metric | DIVISLAB | RELIANCE |
|---|---|---|
| Verdict | Overvalued | Fairly Valued |
| YieldIQ Score | 43/100 | 48/100 |
| Fair Value | ₹2,520 | ₹1,266 |
| Current Price | ₹6,268 | ₹1,353 |
| Margin of Safety | -59.8% | -6.5% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 6/9 | 6/9 |
| ROE | 14.6% | 6.9% |
| Debt / Equity | — | — |
| EV / EBITDA | 46.9× | 14.3× |
| Market Cap | ₹1.66 Lakh Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.